Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction.

Journal of affective disorders - 25 Sept 2013

Murata Yusuke, Kamishioiri Yuko, Tanaka Kenji, Sugimoto Hiroko, Sakamoto Shoko, Kobayashi Daisuke, Mine Kazunori

Abstract excerpt

BACKGROUND: Severe sleepiness and excess sleep duration, "Hypersomnia", induced by paroxetine treatment are generally considered adverse drug reactions, however, our experience indicates that patients with depressive disorder who experience "Hypersomnia" during paroxetine treatment have good clin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Circadian Rhythm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CLOCK Proteins

Share to Cytochrome P-450 CYP2D6

Share to Depressive Disorder

Share to Paroxetine

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 23809402
DOI: 10.1016/j.jad.2013.05.040

Genes

CLOCK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23809402-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction.PMID 23809402Read ↗

Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia.Semantic proximity Read ↗

[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia].Semantic proximity Read ↗

Differences in 24-h autonomic nervous activity between hypersomnia and non-hypersomnia with major depressive disorder outpatients: An observational studySemantic proximity Read ↗

Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients.Semantic proximity Read ↗

Antidepressant-induced jitteriness/anxiety syndrome: systematic review.Semantic proximity Read ↗

Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study.Semantic proximity Read ↗

Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.Semantic proximity Read ↗

A fatal familial insomnia patient newly diagnosed as having depression: A case report.Semantic proximity Read ↗

Recognition and diagnosis of atypical depression.Semantic proximity Read ↗

Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese PatientsSemantic proximity Read ↗

Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.Semantic proximity Read ↗

Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.